Azenta, Inc. (NASDAQ:AZTA) Holdings Lowered by Victory Capital Management Inc.

Victory Capital Management Inc. trimmed its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 67.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,923 shares of the company’s stock after selling 18,358 shares during the period. Victory Capital Management Inc.’s holdings in Azenta were worth $446,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. KBC Group NV lifted its stake in Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after acquiring an additional 698 shares in the last quarter. Assenagon Asset Management S.A. purchased a new stake in Azenta in the 4th quarter worth about $200,000. Empowered Funds LLC purchased a new stake in Azenta in the 4th quarter worth about $293,000. Stephens Inc. AR purchased a new stake in Azenta in the 4th quarter worth about $313,000. Finally, Virtu Financial LLC purchased a new stake in Azenta in the 3rd quarter worth about $352,000. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Stock Performance

Shares of NASDAQ AZTA opened at $37.43 on Friday. The firm has a market cap of $1.71 billion, a price-to-earnings ratio of -12.56 and a beta of 1.52. The business’s 50-day simple moving average is $46.70 and its 200-day simple moving average is $46.63. Azenta, Inc. has a 52 week low of $35.56 and a 52 week high of $63.58.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

AZTA has been the topic of several research reports. Evercore ISI upped their target price on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a research report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and issued a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. Needham & Company LLC upped their target price on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research report on Thursday, February 6th. Finally, TD Cowen raised Azenta to a “hold” rating in a research report on Thursday, February 27th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.